These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31344758)

  • 1. The Impact of Coronary Artery Disease and Statins on Survival After Liver Transplantation.
    Patel SS; Rodriguez VA; Siddiqui MB; Faridnia M; Lin FP; Chandrakumaran A; Laurenzano J; Clinton J; Kowlgi GN; Kirkman D; Sima AP; Liptrap E; Bhati C; Siddiqui MS
    Liver Transpl; 2019 Oct; 25(10):1514-1523. PubMed ID: 31344758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Satapathy SK; Vanatta JM; Helmick RA; Flowers A; Kedia SK; Jiang Y; Ali B; Eason J; Nair SP; Ibebuogu UN
    Transplantation; 2017 Apr; 101(4):793-803. PubMed ID: 28099403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation.
    Patel SS; Guzman LA; Lin FP; Pence T; Reichman T; John B; Celi FS; Liptrap E; Bhati C; Siddiqui MS
    Liver Transpl; 2018 Jul; 24(7):872-880. PubMed ID: 29624871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of statin treatment in patients with coronary artery disease and chronic kidney disease.
    Kaneko H; Yajima J; Oikawa Y; Tanaka S; Fukamachi D; Suzuki S; Sagara K; Otsuka T; Matsuno S; Funada R; Kano H; Uejima T; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
    Heart Vessels; 2014 Jan; 29(1):21-8. PubMed ID: 23430269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients.
    Romero-Cristóbal M; Mombiela T; Caballero A; Clemente A; Fernández-Yunquera A; Diaz-Fontenla F; Rincón D; Ripoll C; Bermejo J; Catalina MV; Matilla AM; Ibáñez-Samaniego L; Pérez-Peña J; López-Baena JÁ; Díaz-Zorita B; Fernández-Avilés F; Salcedo MM; Bañares R
    Liver Transpl; 2019 Aug; 25(8):1177-1186. PubMed ID: 31106506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of coronary artery disease on outcomes after liver transplantation.
    Skaro AI; Gallon LG; Lyuksemburg V; Jay CL; Zhao L; Ladner DP; VanWagner LB; De Wolf AM; Flaherty JD; Levitsky J; Abecassis MM; Gheorghiade M
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17(12):875-885. PubMed ID: 25517876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between coronary artery disease and cardiovascular events early after liver transplantation.
    Patel SS; Lin FP; Rodriguez VA; Bhati C; John BV; Pence T; Siddiqui MB; Sima AP; Abbate A; Reichman T; Siddiqui MS
    Liver Int; 2019 Jul; 39(7):1363-1371. PubMed ID: 30848862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Coronary Angiography in Pre-Liver Transplantation Cardiac Evaluation: Experience From an Asian Transplant Institution.
    Pang NQ; Kow WCA; Law JH; Pan LTT; Lim BLK; Wong CCR; Chang KYS; Ganpathi IS; Madhavan K
    Transplant Proc; 2017 Oct; 49(8):1797-1805. PubMed ID: 28923628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of coronary artery disease in potential liver transplant recipients.
    Hogan BJ; Gonsalkorala E; Heneghan MA
    Liver Transpl; 2017 Mar; 23(3):386-395. PubMed ID: 27875636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
    Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoption of coronary artery disease - Reporting and Data System (CAD-RADS™) and observed impact on medical therapy and systolic blood pressure control.
    Hull RA; Berger JM; Boster JM; Williams MU; Sharp AJ; Fentanes E; Maroules CD; Cury RC; Thomas DM
    J Cardiovasc Comput Tomogr; 2020; 14(5):421-427. PubMed ID: 32005447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates.
    Rachwan RJ; Kutkut I; Timsina LR; Bou Chaaya RG; El-Am EA; Sabra M; Mshelbwala FS; Rahal MA; Lacerda MA; Kubal CA; Fridell JA; Ghabril MS; Bourdillon PD; Mangus RS
    J Hepatol; 2021 Jul; 75(1):142-149. PubMed ID: 33476745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
    D'Avola D; Cuervas-Mons V; Martí J; Ortiz de Urbina J; Lladó L; Jimenez C; Otero E; Suarez F; Rodrigo JM; Gómez MA; Fraga E; Lopez P; Serrano MT; Rios A; Fábrega E; Herrero JI
    Liver Transpl; 2017 Apr; 23(4):498-509. PubMed ID: 28160394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients.
    Xiao J; Yong JN; Ng CH; Syn N; Lim WH; Tan DJH; Tan EY; Huang D; Wong RC; Chew NWS; Tan EXX; Noureddin M; Siddiqui MS; Muthiah MD
    Liver Transpl; 2022 Apr; 28(4):689-699. PubMed ID: 34626045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm.
    Ishii M; Kaikita K; Sato K; Yamanaga K; Miyazaki T; Akasaka T; Tabata N; Arima Y; Sueta D; Sakamoto K; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Soejima H; Hokimoto S; Matsui K; Ogawa H
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
    Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
    Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocholesterolaemia and mortality in patients with coronary artery disease.
    Ndrepepa G; Holdenrieder S; Cassese S; Xhepa E; Fusaro M; Kastrati A
    Eur J Clin Invest; 2020 Feb; 50(2):e13194. PubMed ID: 31863458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease.
    O'Brien EC; Wu J; Schulte PJ; Christian A; Laskey W; Bhatt DL; Peterson ED; Hernandez AF; Fonarow GC
    Am Heart J; 2016 Mar; 173():27-34. PubMed ID: 26920593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels.
    Cho Y; Lee MJ; Choe EY; Jung CH; Joo DJ; Kim MS; Cha BS; Park JY; Kang ES
    Liver Transpl; 2014 May; 20(5):557-63. PubMed ID: 24477986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.